Novonesis (Novozymes) B (OCSE:NSIS B) 3-Year Share Buyback Ratio : -18.90% (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Novonesis (Novozymes) B 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Novonesis (Novozymes) B's current 3-Year Share Buyback Ratio was -18.90%.

The historical rank and industry rank for Novonesis (Novozymes) B's 3-Year Share Buyback Ratio or its related term are showing as below:

OCSE:NSIS B' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -18.9 Med: 1 Max: 6.9
Current: -18.9

During the past 13 years, Novonesis (Novozymes) B's highest 3-Year Share Buyback Ratio was 6.90%. The lowest was -18.90%. And the median was 1.00%.

OCSE:NSIS B's 3-Year Share Buyback Ratio is ranked worse than
93.02% of 859 companies
in the Chemicals industry
Industry Median: -1 vs OCSE:NSIS B: -18.90

Competitive Comparison of Novonesis (Novozymes) B's 3-Year Share Buyback Ratio

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B's 3-Year Share Buyback Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Novonesis (Novozymes) B 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Novonesis (Novozymes) B (OCSE:NSIS B) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Novonesis (Novozymes) B 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OCSE:NSIS B) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA NSISBc:UK 0Q4U:UK NZM:Germany NZM:Germany NZM2:Germany NZM2:Germany NZYM:Austria

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines